Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Andersson, K. Strålin, L. Barregård (Gothenburg, Örebro, Sweden). Serum and urine Clara cell 16-kDa protein in community-acquired pneumonia patients. Eur Respir J 2010; 36: Suppl. 54, 4620

Member's Comments

No comment yet.

Related content which might interest you: High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Serum procalcitonin and C-reactive protein in children with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006 Serum levels of IL-6 in severe community-acquired pneumonia Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010 Measurements usefulness of serum C-reactive protein for management of adult community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 C-reactive protein in community-acquired pneumonia Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Serum procalcitonin and community-acquired pneumonia in childhood Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005 C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005 Clara cell secretory protein and its mRNA expression in induced sputum of acute bacterial exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002 Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia Source: Eur Respir J 2008; 32: 726-732 Year: 2008 Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia Source: Eur Respir J 2005; 25: 688-692 Year: 2005 C-reactive protein levels in community-acquired pneumonia Source: Eur Respir J 2003; 21: 702-705 Year: 2003 Changes in levels of inflammatory markers (procalcitonin, C-reactive protein) in pregnant with community-acquired pneumonia (CAP) Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Clara cell protein (CC16) in serum and urine after exercise challenge Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012 Serum KL-6 level is increased in patients with pneumocystis pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 101s Year: 2006 Serum procalcitonin in pneumococcal pneumonia in children Source: Eur Respir J 2001; 17: 623-627 Year: 2001 Serum procalcitonine (PCT) as a marker of respiratory infection by pseudomonas aeruginosa (PA) in patients with COPD or bronchiectasis Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Serum C-reactive protein (CRP) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003 The influence of prednisolone on C-reactive protein and procalcitonin in patients hospitalised with community-acquired pneumonia Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010 Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012